InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.74
(
-0.01%
)
US TECH 100
18,184.92
(
-0.06%
)
Dow Jones
39,814.88
(
0.02%
)
Brent Oil
82.69
(
-1.01%
)
Bitcoin
69,587.63
(
-2.61%
)
Post# of 251872
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4544
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: mouton29 post# 251393

Thursday, 04/04/2024 10:35:30 AM

Thursday, April 04, 2024 10:35:30 AM

Post# of 251872

one might say Fibrogenic



good one!
I don't follow the company but the CEO sounds like a straight shooter. However he also didn't say the preclinical signal was not there for the second generation so I still think it would have been worth an ask, but it could have been implied. Regardless they have clean data on the 75 patients that have already received LNP2 which bodes well (and yes I assume these patients had the identical delivery w liver targeting moiety but it wasn't expressly stated IIRC)
good luck!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up